US Map / Louisiana
State LA

Clinical Trials in Louisiana

Louisiana is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Louisiana and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.

Right now ClinicalMetric tracks 143 actively recruiting studies with Louisiana sites out of 143 registered in total. The busiest research areas in Louisiana are B Acute Lymphoblastic Leukemia, Venous Leg Ulcer, Ulcerative Colitis. Leading sponsors running trials in the state include Tulane University, National Cancer Institute (NCI), Pennington Biomedical Research Center. By stage, Louisiana trials break down as Phase 1 (8), Phase 2 (32), Phase 3 (53), Phase 4 (4).

All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.

Total Trials
143
Recruiting Now
143
← Back to US Map
Top Conditions in Louisiana
B Acute Lymphoblastic Leukemia (3)Venous Leg Ulcer (3)Ulcerative Colitis (3)Obesity (3)Malignant Solid Neoplasm (2)Human Immunodeficiency Virus (2)Solid Tumor (2)Prostate Adenocarcinoma (2)Mitral Valve Insufficiency (2)Chronic Low-back Pain (2)Heart Failure (2)Alzheimer Disease (2)

Frequently Asked Questions — Clinical Trials in Louisiana

How many clinical trials are currently recruiting in Louisiana?
ClinicalMetric currently tracks 143 actively recruiting clinical trials with at least one location in Louisiana. The total number of registered studies—including active but not currently enrolling trials—is 143. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Louisiana?
Louisiana hosts clinical trials across a broad range of medical conditions, including B Acute Lymphoblastic Leukemia, Venous Leg Ulcer, Ulcerative Colitis, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Louisiana serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Louisiana?
To join a clinical trial in Louisiana, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Louisiana maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in Louisiana

NCT05702229 Phase 2
Recruiting
Novel Combinations in Participants With Locally Advanced Unresectable or Metasta...
Condition
Gastric Cancer
Enrollment
163 pts
Location
United States, China, Japan
Sponsor
AstraZeneca
View Trial →
NCT07077902 Phase 2
Recruiting
A Study for Evaluating Safety & Efficacy of Topical Roflumilast 0.3% Foam in Hid...
Condition
Hidradenitis Suppurativa
Enrollment
10 pts
Location
United States
Sponsor
Tulane University
View Trial →
NCT07061977 Phase 3
Recruiting
Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemor...
Condition
Locally Advanced Cervical Adenocarcinoma
Enrollment
336 pts
Location
United States, Puerto Rico
Sponsor
National Cancer Institute (NCI
View Trial →
NCT06746883 N/A
Recruiting
A Study to Assess the Safety and Risk of Hypersensitivity Reactions of Sulbactam...
Condition
Acinetobacter Baumannii-calcoaceticus Complex Infection (ABC)
Enrollment
100 pts
Location
United States
Sponsor
Innoviva Specialty Therapeutic
View Trial →
NCT04726241 Phase 1, Phase 2
Recruiting
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marr...
Condition
Acute Lymphoblastic Leukemia
Enrollment
960 pts
Location
United States, Australia, Canada
Sponsor
PedAL BCU, LLC
View Trial →
NCT07577856 Phase 3
Recruiting
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcer...
Condition
Colitis, Ulcerative
Enrollment
644 pts
Location
United States, Argentina, Australia
Sponsor
Janssen Research & Development
View Trial →
NCT06011551 N/A
Recruiting
HYDRAFIL-D: HYDRogel Augmentation For Intervertebral Lumbar Discs
Condition
Degenerative Disc Disease (DDD)
Enrollment
225 pts
Location
United States, Canada
Sponsor
ReGelTec, Inc.
View Trial →
NCT06958328 Phase 3
Recruiting
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
Condition
Locally Advanced Unresectable Pancreatic Ductal Adenocarcinoma
Enrollment
356 pts
Location
United States, Canada
Sponsor
NRG Oncology
View Trial →
NCT06598943 Phase 2
Recruiting
A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Seve...
Condition
Ulcerative Colitis
Enrollment
143 pts
Location
United States, Argentina, Belgium
Sponsor
Eli Lilly and Company
View Trial →
NCT04071847 N/A
Recruiting
Abbott DBS Post-Market Study of Outcomes for Indications Over Time
Condition
Movement Disorders
Enrollment
1,000 pts
Location
United States, Australia, Finland
Sponsor
Abbott Medical Devices
View Trial →
NCT06249126 N/A
Recruiting
Primary Subtalar Arthrodesis for Calcaneal Fractures
Condition
Calcaneus Fracture
Enrollment
218 pts
Location
United States
Sponsor
Wake Forest University Health
View Trial →
NCT05156398 Phase 3
Recruiting
Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migrai...
Condition
Migraine
Enrollment
640 pts
Location
United States, Canada, France
Sponsor
Pfizer
View Trial →
NCT04956549 N/A
Recruiting
Reducing African American's Alzheimer's Risk Through Exercise-Mild Cognitive Imp...
Condition
Dementia of Alzheimer Type
Enrollment
144 pts
Location
United States
Sponsor
Pennington Biomedical Research
View Trial →
NCT07013747 Phase 1, Phase 2
Recruiting
Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Pa...
Condition
Acne
Enrollment
228 pts
Location
United States
Sponsor
Sanofi Pasteur, a Sanofi Compa
View Trial →
NCT07136012 Phase 3
Recruiting
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a)...
Condition
Cardiovascular Disease
Enrollment
11,000 pts
Location
United States, Australia, Canada
Sponsor
Amgen
View Trial →
NCT06632444 Phase 3
Recruiting
LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease...
Condition
Metabolic Dysfunction Associated Steatohepatitis (MASH)
Enrollment
1,800 pts
Location
United States, Argentina, Australia
Sponsor
Boehringer Ingelheim
View Trial →
NCT05812807 Phase 3
Recruiting
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who H...
Condition
Anatomic Stage II Breast Cancer AJCC v8
Enrollment
1,295 pts
Location
United States, Canada, Puerto Rico
Sponsor
Alliance for Clinical Trials i
View Trial →
NCT06920563 N/A
Recruiting
Remote Postpartum Blood Pressure Monitoring and Cardiovascular Education
Condition
Pre-Eclampsia; Complicating Pregnancy
Enrollment
296 pts
Location
United States
Sponsor
Ochsner Health System
View Trial →
NCT06388421 N/A
Recruiting
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension As...
Condition
Pulmonary Hypertension Due to Lung Diseases and Hypoxia
Enrollment
900 pts
Location
United States, Puerto Rico
Sponsor
United Therapeutics
View Trial →
NCT07415044 Phase 2
Recruiting
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
Condition
Ulcerative Colitis (UC)
Enrollment
1,431 pts
Location
United States, Argentina, Brazil
Sponsor
Eli Lilly and Company
View Trial →
NCT07374107 N/A
Recruiting
MIHRA - Patient-Rooted Insights for Shaping Myositis Science (PRISMS)
Condition
IBM
Enrollment
700 pts
Location
United States
Sponsor
Myositis International Health
View Trial →
NCT06712407 Phase 4
Recruiting
Efficacy and Safety of Extended TARPEYO® Treatment Beyond 9 Months in Adult Pati...
Condition
IgA Nephropathy
Enrollment
60 pts
Location
United States, Puerto Rico
Sponsor
Calliditas Therapeutics AB
View Trial →
NCT06430801 Phase 3
Recruiting
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Partici...
Condition
Crohn's Disease
Enrollment
1,200 pts
Location
United States, Australia, Austria
Sponsor
Merck Sharp & Dohme LLC
View Trial →
NCT06338995 Phase 3
Recruiting
A Study of Lebrikizumab (LY3650150) in Participants With Chronic Rhinosinusitis ...
Condition
Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)
Enrollment
510 pts
Location
United States, Argentina, Belgium
Sponsor
Eli Lilly and Company
View Trial →
NCT05919511 N/A
Recruiting
Observational Study for Patients at Risk for Chronic Graft-Versus-Host Disease
Condition
cGVHD
Enrollment
1,500 pts
Location
United States
Sponsor
Incyte Corporation
View Trial →
Page 5 of 6 — 143 trials total
← Prev Next →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology